DA
CVS icon

Drake & Associates’s CVS Health CVS Stock Holding History

Drake & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,724
Closed -$202K – 76
2023
Q1 		$202K Sell
2,724
-207
-7% -$17.4K 0.1% 71
2022
Q4 		$273K Sell
2,931
-22
-0.7% -$2.12K 0.14% 58
2022
Q3 		$282K Buy
2,953
+87
+3% +$8.61K 0.16% 39
2022
Q2 		$266K Buy
+2,866
New +$280K 0.15% 43

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Drake & Associates's CVS Position: Q2 2023 in Review

Drake & Associates sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,724 shares — an estimated $202K sold.

Drake & Associates first reported a position in CVS in Q2 2022 and held it in 4 quarters. The position peaked at $282K in Q3 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Drake & Associates reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Drake & Associates sold 2,724 CVS Health shares in Q2 2023, an estimated $202K.
  • Drake & Associates first reported a position in CVS Health in Q2 2022 and held it in 4 quarters.
  • Drake & Associates's CVS Health position peaked at $282K in Q3 2022.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Drake & Associates's 13F filing for Q2 2023, filed 11 Jul 2023.